Marieke W. Schoonen
Uxbridge, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.
Journal: Clinical pharmacology and therapeutics
Published: October 24, 2024
The DA VINCI study: is Ireland achieving ESC/EAS guideline-directed LDL-C goals?
Journal: Irish journal of medical science
Published: December 18, 2021
Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia.
Journal: European journal of haematology
Published: October 09, 2019
Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: February 14, 2019
The current total economic burden of diabetes mellitus in the Netherlands.
Journal: The Netherlands journal of medicine
Published: September 29, 2017
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Journal: European journal of haematology
Published: August 24, 2016
A compilation of research working groups on drug utilisation across Europe.
Journal: BMC research notes
Published: September 30, 2013
Sources of European drug consumption data at a country level.
Journal: International journal of public health
Published: June 20, 2013
The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
Journal: Journal of medical economics
Published: April 27, 2012
Quality of urological cancer diagnoses in the Danish National Registry of Patients.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: March 22, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026